
Arbutus Biopharma Corp
ABUSHealthcare|Biotechnology|USA
$4.79
-0.34 (-6.52%)
Tangible Book
$1.32
Graham Number
$4.93
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812",
"202912"
],
"revenue_estimate": [
91.1,
2.7,
55.95,
173.53
],
"ebit_estimate": [
153,
-21.3,
-36.48,
66.87
],
"ebitda_estimate": [
null,
null,
null,
null
],
"net_income_estimate": [
156.1,
-18.1,
-29.72,
73.89
],
"per_share_eps_estimate": [
0.3,
-0.09,
-0.14,
0.34
],
"eps_nri_estimate": [
0.3,
-0.09,
-0.14,
0.34
],
"dividend_estimate": [
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null
],
"pretax_income_estimate": [
156.1,
-18.1,
-29.72,
73.89
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null
],
"gross_margin_estimate": [
null,
null,
null,
null
],
"operating_cash_flow_estimate": [
null,
null,
null,
null
],
"pettm_estimate": [
16.24,
0,
0,
14.09
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "0.00",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": null,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}
quarterly
{
"date": [
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712"
],
"revenue_estimate": [
0.45,
0.45,
0.4,
0.7,
0.7,
0.7,
0.7
],
"ebit_estimate": [
-5.3,
-5.3,
-5.3,
-5.3,
-5.3,
-5.3,
-5.3
],
"ebitda_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"net_income_estimate": [
-4.5,
-4.5,
-4.5,
-4.5,
-4.5,
-4.5,
-4.5
],
"per_share_eps_estimate": [
-0.03,
-0.03,
-0.03,
-0.02,
-0.02,
-0.02,
-0.02
],
"eps_nri_estimate": [
-0.03,
-0.03,
-0.03,
-0.02,
-0.02,
-0.02,
-0.02
],
"dividend_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
-4.5,
-4.5,
-4.5,
-4.5,
-4.5,
-4.5,
-4.5
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pettm_estimate": [
0,
0,
0,
0,
null,
null,
null
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "0.00",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": null,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}